LIMA1 anticorps (N-Term)
Aperçu rapide pour LIMA1 anticorps (N-Term) (ABIN953171)
Antigène
Voir toutes LIMA1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 134-163, N-Term
-
Specificité
- This antibody recognizes Human LIMA1 (N-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 134-163 amino acids from the N-terminal region of human LIMA1
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- LIMA1 (LIM Domain and Actin Binding 1 (LIMA1))
-
Autre désignation
- LIMA1
-
Sujet
- EPLIN is a cytoskeleton-associated protein that inhibits actin filament depolymerization and cross-links filaments in bundles (Maul et al., 2003 [PubMed 12566430]).Synonyms: EPLIN, Epithelial protein lost in neoplasm, LIM domain and actin-binding protein 1, LIMA1, SREBP3
-
Poids moléculaire
- 85226 Da
-
ID gène
- 51474
-
NCBI Accession
- NP_001107018
Antigène
-